The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2025 | How to approach sequencing in CLL amid expanding treatment options
Meghan Thompson, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the importance of sequencing in chronic lymphocytic leukemia (CLL) treatment, highlighting that clinical trial data often lack sequencing insights. Dr Thompson emphasizes the value of using real-world and retrospective data to provide information until clinical trial results become available. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
